Urban Wealth Management »

Bioxcel Therapeutics shares owned by Urban Wealth Management

Quarter-by-quarter ownership of Bioxcel Therapeutics (BTAI) shares owned by Urban Wealth Management from 13F filings

Historical chart of Urban Wealth Management investment in Bioxcel Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Bioxcel Therapeutics held by Urban Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bioxcel Therapeutics by Urban Wealth Management

Quarter filed Position value Share count Share price at filing
2022-06-30 $23k 1.7k 13.33

More positions owned by Urban Wealth Management

Alphabet Cap Stk Cl A (GOOGL)
Verizon Communications (VZ)
Ishares U S Etf Tr Commodity Curve (CCRV)
DaVita (DVA)
Ishares Core Msci Emkt (IEMG)
Ishares Tr Core Msci Eafe (IEFA)
Ishares Tr Us Infrastruc (IFRA)
Spdr Ser Tr Portfolio Ln Tsr (SPTL)
Tesla Motors (TSLA)
Alphabet Cap Stk Cl C (GOOG)
salesforce (CRM)
American Tower Reit (AMT)
Nushares Etf Tr Nuveen Esg Midvl (NUMV)
NVIDIA Corporation (NVDA)
Ishares Tr Core High Dv Etf (HDV)

View all positions for Urban Wealth Management

Top funds holding Bioxcel Therapeutics

Vanguard Group
BlackRock
Geode Capital Management
Wells Fargo & Company
Renaissance Technologies
Millennium Management
Bank of America Corporation
State Street Corporation
Citadel Advisors
Jane Street
Susquehanna International
Bnp Paribas Arbitrage, Snc
Northern Trust
Arete Wealth Advisors
Diversify Wealth Management

View all funds holding Bioxcel Therapeutics